These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 31373223)

  • 1. Pretreatment blood biomarkers predict pathologic responses to neo-CRT in patients with locally advanced rectal cancer.
    Li A; He K; Guo D; Liu C; Wang D; Mu X; Yu J
    Future Oncol; 2019 Oct; 15(28):3233-3242. PubMed ID: 31373223
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic Value of Pretreatment Serum CA199 in Patients with Locally Advanced Rectal Cancer Treated with CRT Followed by TME with Normal Pretreatment Carcinoembryonic Antigen Levels.
    Huang D; Lin Q; Song J; Xu B
    Dig Surg; 2021; 38(1):24-29. PubMed ID: 33171467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of changes in serum carcinoembryonic antigen levels for preoperative chemoradiotherapy response in locally advanced rectal cancer.
    Cheong C; Shin JS; Suh KW
    World J Gastroenterol; 2020 Nov; 26(44):7022-7035. PubMed ID: 33311947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-reactive protein as predictor of recurrence in patients with rectal cancer undergoing chemoradiotherapy followed by surgery.
    Toiyama Y; Inoue Y; Saigusa S; Kawamura M; Kawamoto A; Okugawa Y; Hiro J; Tanaka K; Mohri Y; Kusunoki M
    Anticancer Res; 2013 Nov; 33(11):5065-74. PubMed ID: 24222151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting Pathological Complete Regression with Haematological Markers During Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.
    Lee JH; Song C; Kang SB; Lee HS; Lee KW; Kim JS
    Anticancer Res; 2018 Dec; 38(12):6905-6910. PubMed ID: 30504408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer with serum biomarkers.
    Clarke TL; White DA; Osborne ME; Shaw AM; Smart NJ; Daniels IR
    Ann R Coll Surg Engl; 2017 May; 99(5):373-377. PubMed ID: 28462648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analyses of predictive factors for pathological complete remission in neoadjuvant therapy for locally advanced rectal cancer.
    Yang J; Ling X; Tang W; Hu D; Zhou H; Yin G
    J BUON; 2019; 24(1):77-83. PubMed ID: 30941954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reappraisal of pretreatment carcinoembryonic antigen in patients with rectal cancer receiving preoperative chemoradiotherapy.
    Yeo SG; Kim DY; Chang HJ; Park JW; Oh JH; Kim BC; Baek JY; Kim SY; Kim TH
    Tumori; 2013; 99(1):93-9. PubMed ID: 23549007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Capecitabine (Xeloda) vs. Combination of Capecitabine and Oxaliplatin (XELOX) as Neoadjuvant CRT for Locally Advanced Rectal Cancer.
    Yaghobi Joybari A; Azadeh P; Babaei S; Hosseini Kamal F
    Pathol Oncol Res; 2019 Oct; 25(4):1599-1605. PubMed ID: 30712194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating lymphocyte number has a positive association with tumor response in neoadjuvant chemoradiotherapy for advanced rectal cancer.
    Kitayama J; Yasuda K; Kawai K; Sunami E; Nagawa H
    Radiat Oncol; 2010 Jun; 5():47. PubMed ID: 20525293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of the preoperative chemoradiotherapy response for rectal cancer by peripheral blood lymphocyte subsets.
    Tada N; Kawai K; Tsuno NH; Ishihara S; Yamaguchi H; Sunami E; Kitayama J; Oba K; Watanabe T
    World J Surg Oncol; 2015 Feb; 13():30. PubMed ID: 25890185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinoembryonic antigen (CEA) level, CEA ratio, and treatment outcome of rectal cancer patients receiving pre-operative chemoradiation and surgery.
    Yang KL; Yang SH; Liang WY; Kuo YJ; Lin JK; Lin TC; Chen WS; Jiang JK; Wang HS; Chang SC; Chu LS; Wang LW
    Radiat Oncol; 2013 Mar; 8():43. PubMed ID: 23452434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can pretreatment blood biomarkers predict pathological response to neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer?
    Morais M; Fonseca T; Machado-Neves R; Honavar M; Coelho AR; Lopes J; Barbosa E; Guerreiro E; Carneiro S
    Future Oncol; 2021 Dec; 17(35):4947-4957. PubMed ID: 34734533
    [No Abstract]   [Full Text] [Related]  

  • 14. [Risk factors related to lymph node metastases after neoadjuvant therapy for locally advanced rectal cancer].
    Zeng ZF; Ding PR; Pan ZZ; Lin JZ; Li LR; Lu ZH; Wu XJ; Kong LH; Zhou ZG; Wan DS
    Ai Zheng; 2009 Sep; 28(9):923-7. PubMed ID: 19728908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil-to-Lymphocyte Ratio in Rectal Cancer-Novel Biomarker of Tumor Immunogenicity During Radiotherapy or Confounding Variable?
    Braun LH; Baumann D; Zwirner K; Eipper E; Hauth F; Peter A; Zips D; Gani C
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31108935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of sensitivity to preoperative chemoradiotherapy of rectal adenocarcinoma.
    Yan H; Wang R; Zhu K; Zhao W; Jiang S; Feng R; Xu X; Meng X; Sun H; Zhang H; Mu D; Xu Z
    Tumori; 2011; 97(6):717-23. PubMed ID: 22322837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of pre- to post-chemoradiotherapy s-CEA reduction ratio in rectal cancer patients treated with preoperative chemoradiotherapy and curative resection.
    Kim CW; Yu CS; Yang SS; Kim KH; Yoon YS; Yoon SN; Lim SB; Kim JC
    Ann Surg Oncol; 2011 Nov; 18(12):3271-7. PubMed ID: 21537868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined modality therapy for rectal cancer: the relative value of posttreatment versus pretreatment CEA as a prognostic marker for disease recurrence.
    Song S; Hong JC; McDonnell SE; Koong AC; Minsky BD; Chang DT; Liauw SL
    Ann Surg Oncol; 2012 Aug; 19(8):2471-6. PubMed ID: 22327251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive Value of Leukocyte- and Platelet-Derived Ratios in Rectal Adenocarcinoma.
    Ward WH; Goel N; Ruth KJ; Esposito AC; Lambreton F; Sigurdson ER; Meyer JE; Farma JM
    J Surg Res; 2018 Dec; 232():275-282. PubMed ID: 30463730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CEA - a predictor for pathologic complete response after neoadjuvant therapy for rectal cancer.
    Wallin U; Rothenberger D; Lowry A; Luepker R; Mellgren A
    Dis Colon Rectum; 2013 Jul; 56(7):859-68. PubMed ID: 23739192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.